Breaking News, Financial News

Financial Reports: ICON

Revenues rise at CRO

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ICON 1Q13 1Q Revenues: $317 million (+26%) 1Q Earnings: $22 million (+147%) Comments: ICON reported net new business of $422 million and a book-to-bill ratio of 1.3. During 1Q13 the company recorded a charge of $4.4 million in restructuring costs and other items....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters